InChI=1S/C55H83N17O21S3/c1- 20- 33(69- 46(72- 44(20) 58) 25(12- 31(57) 76) 64- 13- 24(56) 45(59) 82) 50(86) 71- 35(41(26- 14- 61- 19- 65- 26) 91- 54- 43(39(80) 37(78) 29(15- 73) 90- 54) 92- 53- 40(81) 42(93- 55(60) 88) 38(79) 30(16- 74) 89- 53) 51(87) 66- 22(3) 36(77) 21(2) 47(83) 70- 34(23(4) 75) 49(85) 63- 10- 8- 32- 67- 28(18- 94- 32) 52- 68- 27(17- 95- 52) 48(84) 62- 9- 7- 11- 96(5) 6/h14,17- 19,21- 25,29- 30,34- 43,53- 54,64,73- 75,77- 81H,7- 13,15- 16,56H2,1- 6H3,(H13- ,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88) /p+1/t21- ,22+,23+,24- ,25- ,29- ,30+,34- ,35- ,36- ,37+,38+,39- ,40- ,41- ,42- ,43- ,53+,54- /m0/s1 |
OYVAGSVQBOHSSS-UAPAGMARSA-O |
[H] [C@] (C) (NC(=O) [C@@] ([H] ) (NC(=O) c1nc(nc(N) c1C) [C@H] (CC(N) =O) NC[C@H] (N) C(N) =O) [C@@] ([H] ) (O[C@@H] 1O[C@@H] (CO) [C@@H] (O) [C@H] (O) [C@@H] 1O[C@H] 1O[C@H] (CO) [C@@H] (O) [C@H] (OC(N) =O) [C@@H] 1O) c1c[nH] cn1) [C@@H] (O) [C@H] (C) C(=O) N[C@] ([H] ) (C(=O) NCCc1nc(cs1) - c1nc(cs1) C(=O) NCCC[S+] (C) C) [C@@] ([H] ) (C) O |
|
Streptomyces verticillus
(NCBI:txid29309)
|
of strain
ATCC15003
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
chelator
A ligand with two or more separate binding sites that can bind to a single metallic central atom, forming a chelate.
(via chelate-forming peptide )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via bleomycin )
(via peptide antibiotic )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(βR)- Nα- {[6- amino- 2- ((1S)- 3- amino- 1- {[(2S)- 2,3- diamino- 3- oxopropyl]amino}- 3- oxopropyl)- 5- methylpyrimidin- 4- yl]carbonyl}- β- {2- O- [3- O- (aminocarbonyl)- α- D- mannopyranosyl]- α- L- gulopyranosyloxy}- N- [(1R,2S,3S)- 5- ({(1S,2R)- 1- [({2- [4- ({[3- (dimethylsulfonio)propyl]amino}carbonyl)- 2,4'- bi- 1,3- thiazol- 2'- yl]ethyl}amino)carbonyl]- 2- hydroxypropyl}amino)- 3- hydroxy- 4- methyl- 5- oxopentan- 2- yl]- L- histidinamide
|
Bleomycin
|
ChEMBL
|
Bleomycin
|
KEGG COMPOUND
|
bleomycin A2
|
ChEMBL
|
BLEOMYCIN A2
|
PDBeChem
|
Bleomycin A2
|
KEGG COMPOUND
|
bleomycin A2
|
ChemIDplus
|
N1-[3-(dimethylsulfonio)propyl]bleomycinamide
|
ChemIDplus
|
Bleomycin
|
Wikipedia
|
BLM
|
PDBeChem
|
C00018738
|
KNApSAcK
|
C06854
|
KEGG COMPOUND
|
C15773
|
KEGG COMPOUND
|
D07535
|
KEGG DRUG
|
View more database links |
11056-06-7
|
CAS Registry Number
|
KEGG COMPOUND
|
11116-31-7
|
CAS Registry Number
|
KEGG COMPOUND
|
11116-31-7
|
CAS Registry Number
|
ChemIDplus
|
1667354
|
Gmelin Registry Number
|
Gmelin
|
4379083
|
Beilstein Registry Number
|
Beilstein
|
12477361
|
PubMed citation
|
ChEMBL
|
|